Impact of Sodium Fluctuations on Prognosis in Hospitalized Patients: A Retrospective Observational Study
Keywords:
hyponatremia, hypernatremi, Mixed Dysnatremia, Mortality, Sodium Variation, HospitalizationAbstract
BACKGROUND: In hospitalized patients, electrolyte alterations have a significant impact in patient outcomes particularly dysnatremias. Hyponatremia and hypernatremia are the two main sodium disturbances, which have been associated with increased morbidity and mortality. Nevertheless, the particular influence of sodium variations during hospitalization in mortality risk remains an area less studied and therefore less understood. Our study seeks to investigate the relationship between sodium fluctuations and mortality in hospitalized patients at Mexicali General Hospital, Mexico.
METHODS: We conducted a retrospective, single-center, observational study at a secondary care hospital in Mexicali, Mexico, from January 1, 2023, to May 31, 2023. The study included adult patients with normonatremia at admission (serum sodium levels between 135-145 mmol/L), with minimum hospitalization time of 48 hours and at least two sodium measurements. Patients with chronic kidney disease, tuberculosis, or pregnancy were excluded. Dysnatremia was defined as serum sodium levels outside the 135-145 mmol/L range during hospitalization. The primary outcome was to establish a relationship between the sodium fluctuation and mortality among all the patients that were hospitalized; while secondary outcomes demographic characteristics and a multivariable analysis to assess how these variables influenced the outcome Statistical analyses included ANOVA, Fisher's exact test, unpaired t-tests, Kaplan-Meier survival curves, and multivariate analysis using the Cox Proportional Hazard Model.
RESULTS: We had 284 patients from which 117 (41.2%) developed dysnatremia, with the highest incidence occurring in the intensive care unit (73.3%) and internal medicine services (50.4%). A total of 58 patients (20.4%) died during hospitalization, and among those, 36 (62.1%) had developed dysnatremia, with hypernatremia being more common. The odds ratio for mortality among dysnatremic patients was 2.7 (95% CI: 1.5-4.8, p=0.0009). Patients who developed hyponatremia had a mean length of stay of 12.28 days compared to 9.12 days for eunatremic patients. although, mixed dysnatremia was associated with the longest hospital stay (22.33 days). Patients with greater sodium fluctuations had a higher mortality risk, with a mean sodium variation difference of 7.01 mEq/L (95% CI: 4.99-9.03, p<0.0001) between survivors and non-survivors. Multivariate analysis revealed that age and serum creatinine at admission were significant predictors of mortality, with each year of age increasing the risk of death by 1.35% (p=0.027) and each 0.1 mg/dL increase in creatinine raising the risk by 1.16% (p=0.008).
CONCLUSION: Our findings underscore the importance of monitoring and managing sodium levels in hospitalized patients. Fluctuations in serum sodium levels during hospitalization are associated with increased mortality risk, particularly greater levels than 145 mmol/l and those in intensive care and internal medicine settings. Strategies aimed at the importance of closely monitoring and managing sodium levels improve outcomes in-hospital stay. Future research should focus on developing targeted interventions to stabilize sodium levels and further explore the mechanisms linking sodium dysregulation to mortality.
References
Bernal A, Zafra MA, Simón MJ, Mahía J. Sodium Homeostasis, a Balance Necessary for Life. Nutrients. 2023;15(2):395.
Reynolds RM, Padfield PL, Seckl JR. Disorders of sodium balance. BMJ. 2006;332(7543):702-5.
Verbalis JG, Goldsmith SR, Greenberg A, Korzelius C, Schrier WR, Sterns RH, et al. Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations. Am J Med. 2013;126(10 Suppl 1):S1-42
Arzhan S, Roumelioti ME, Litvinovich I, Bologa CG, Myers OB, Unruh ML. Hypernatremia in Hospitalized Patients: A Large Population-Based Study. Kidney360. 2022;3(7):1144-1157.
StatPearls. Hyponatremia. Available from: https://www.ncbi.nlm.nih.gov/books/NBK470386/. Last updated Jun 14, 2023; cited Jun 22, 2023.
Jameson JL, Loscalzo J. Harrison’s Nephrology and acid-base disorders. 3rd ed. New York: McGraw-Hill Education; 2016.
Mentrasti G, Scortichini L, Torniai M, Giampieri R, Morgese F, Rinaldi S, et al. Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH): Optimal Management. Ther Clin Risk Manag. 2020;16:663-672.
Hernandez Rios JJ, Guardado Vindiola JA, Cordova Erberk J, Wilhelmy Ledesma KL, Sterling Carrillo PA, Estrada Rodríguez M, et al. Hyponatremia incidence and its association with mortality in patients with pulmonary tuberculosis observational study. IJMSCRS. 2022;2(3):218–226.
Lu H, Vollenweider P, Kissling S, Marques-Vidal P. Prevalence and Description of Hyponatremia in a Swiss Tertiary Care Hospital: An Observational Retrospective Study. Front Med (Lausanne). 2020;7:512.
Upadhyay A, Jaber BL, Madias NE. Incidence and prevalence of hyponatremia. Am J Med. 2006;119(7 Suppl 1):S30-5.
Muhsin SA, Mount DB. Diagnosis and treatment of hypernatremia. Best Pract Res Clin Endocrinol Metab. 2016;30(2):189-203.
Chuang C, Guo YW, Chen HS. Corrected sodium levels for hyperglycemia is a better predictor than measured sodium levels for clinical outcomes among patients with extreme hyperglycemia. J Chin Med Assoc. 2020;83(9):845-851.
Swart RM, Hoorn EJ, Betjes MG, Zietse R. Hyponatremia and inflammation: the emerging role of interleukin-6 in osmoregulation. Nephron Physiol. 2011;118(2):45-51.
Chawla A, Sterns RH, Nigwekar SU, Cappuccio JD. Mortality and serum sodium: do patients die from or with hyponatremia? Clin J Am Soc Nephrol. 2011;6(5):960-5.
Lu DY, Cheng HM, Cheng YL, Hsu PF, Huang WM, Guo CY, et al. Hyponatremia and Worsening Sodium Levels Are Associated With Long-Term Outcome in Patients Hospitalized for Acute Heart Failure. J Am Heart Assoc. 2016;5(3):e002668.
John S, Thuluvath PJ. Hyponatremia in cirrhosis: pathophysiology and management. World J Gastroenterol. 2015;21(11):3197-205.
Turkmen E, Karatas A, Altindal M. Factors affecting prognosis of the patients with severe hyponatremia. Nefrologia (Engl Ed). 2022;42(2):196-202.
Hao J, Li Y, Zhang X, Pang C, Wang Y, Nigwekar SU, et al. The prevalence and mortality of hyponatremia is seriously underestimated in Chinese general medical patients: an observational retrospective study. BMC Nephrol. 2017;18(1):328.
Lombardi G, Ferraro PM, Calvaruso L, Naticchia A, D'Alonzo S, Gambaro G. Sodium Fluctuations and Mortality in a General Hospitalized Population. Kidney Blood Press Res. 2019;44(4):604-614.
Waikar SS, Mount DB, Curhan GC. Mortality after hospitalization with mild, moderate, and severe hyponatremia. Am J Med. 2009;122(9):857-865.
Funk GC, Lindner G, Druml W, Metnitz B, Schwarz C, Bauer P, et al. Incidence and prognosis of dysnatremias present on ICU admission. Intensive Care Med. 2010;36(2):304-311.
Holland-Bill L, Christiansen CF, Heide-Jørgensen U, Ulrichsen SP, Ring T, Jørgensen JO, et al. Hyponatremia and mortality risk: a Danish cohort study of 279 508 acutely hospitalized patients. Eur J Endocrinol. 2015;173(1):71-81.
Gankam Kengne F, Andres C, Sattar L, Melot C, Decaux G. Mild hyponatremia and risk of fracture in the ambulatory elderly. QJM. 2008;101(7):583-588.
Renneboog B, Musch W, Vandemergel X, Manto MU, Decaux G. Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits. Am J Med. 2006;119(1):71.e1-71.e8.
Hoorn EJ, Lindemans J, Zietse R. Development of severe hyponatremia in hospitalized patients: treatment-related risk factors and inadequate management. Nephrol Dial Transplant. 2006;21(1):70-76.
Adrogue HJ, Madias NE. Hyponatremia. N Engl J Med. 2000;342(21):1581-1589.
Spasovski G, Vanholder R, Allolio B, Annane D, Ball S, Bichet D, et al. Clinical practice guideline on diagnosis and treatment of hyponatremia. Eur J Endocrinol. 2014;170(3):G1-G47.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2024 Manlio Avila
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- The Author retains copyright in the Work, where the term “Work” shall include all digital objects that may result in subsequent electronic publication or distribution.
- Upon acceptance of the Work, the author shall grant to the Publisher the right of first publication of the Work.
- The Author shall grant to the Publisher and its agents the nonexclusive perpetual right and license to publish, archive, and make accessible the Work in whole or in part in all forms of media now or hereafter known under a Creative Commons Attribution 4.0 International License or its equivalent, which, for the avoidance of doubt, allows others to copy, distribute, and transmit the Work under the following conditions:
- Attribution—other users must attribute the Work in the manner specified by the author as indicated on the journal Web site; with the understanding that the above condition can be waived with permission from the Author and that where the Work or any of its elements is in the public domain under applicable law, that status is in no way affected by the license.
- The Author is able to enter into separate, additional contractual arrangements for the nonexclusive distribution of the journal's published version of the Work (e.g., post it to an institutional repository or publish it in a book), as long as there is provided in the document an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post online a prepublication manuscript (but not the Publisher’s final formatted PDF version of the Work) in institutional repositories or on their Websites prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. Any such posting made before acceptance and publication of the Work shall be updated upon publication to include a reference to the Publisher-assigned DOI (Digital Object Identifier) and a link to the online abstract for the final published Work in the Journal.
- Upon Publisher’s request, the Author agrees to furnish promptly to Publisher, at the Author’s own expense, written evidence of the permissions, licenses, and consents for use of third-party material included within the Work, except as determined by Publisher to be covered by the principles of Fair Use.
- The Author represents and warrants that:
- the Work is the Author’s original work;
- the Author has not transferred, and will not transfer, exclusive rights in the Work to any third party;
- the Work is not pending review or under consideration by another publisher;
- the Work has not previously been published;
- the Work contains no misrepresentation or infringement of the Work or property of other authors or third parties; and
- the Work contains no libel, invasion of privacy, or other unlawful matter.
- The Author agrees to indemnify and hold Publisher harmless from the Author’s breach of the representations and warranties contained in Paragraph 6 above, as well as any claim or proceeding relating to Publisher’s use and publication of any content contained in the Work, including third-party content.
Enforcement of copyright
The IJMS takes the protection of copyright very seriously.
If the IJMS discovers that you have used its copyright materials in contravention of the license above, the IJMS may bring legal proceedings against you seeking reparation and an injunction to stop you using those materials. You could also be ordered to pay legal costs.
If you become aware of any use of the IJMS' copyright materials that contravenes or may contravene the license above, please report this by email to contact@ijms.org
Infringing material
If you become aware of any material on the website that you believe infringes your or any other person's copyright, please report this by email to contact@ijms.org